TENS

Tenshi Life Sciences is a global pharmaceutical company and investment vehicle focused on developing advanced finished dosage products and active pharmaceutical ingredients (APIs). The company leverages proprietary technology platforms, such as the InstaPill rapid-dissolve tablet technology and thermostable probiotics, to create high-value, cost-effective healthcare solutions. Tenshi operates through a robust global infrastructure, including manufacturing facilities and strategic partnerships, to serve both emerging and regulated markets. Its business model encompasses drug research and development, contract manufacturing (CDMO), and the commercialization of niche generic and innovative products.